Thiotepa Powder For Solution For Injection 15Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Thiotepa: Powder for solution for injection (15mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

THIOTEPA (thye oh TEP a) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat many types of cancer like breast cancer, ovarian cancer, bladder cancer, and lymphoma.

In-Depth Information
Select a Medication

Thiotepa 15mg Powder for Injection

NDC: 001439565
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer, Non-Hodgkin's Lymphoma (NHL), Pericardial Effusion, Hodgkin's Disease, Ovarian Cancer, Pleural Effusion, Peritoneal Effusion, Bladder Cancer

Sometimes used for but not FDA approved for the following conditions:
Carcinomatous Meningitis, Stem Cell Transplant Preparation, Soft-tissue Sarcoma

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Thiotepa 15mg Powder for Injection

Reported Side Effects for Thiotepa 15mg Powder for Injection

Secondary Malignancy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Bladder Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Painful Bloody Urine Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Thiotepa

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5